MedicineMaterials ScienceChemistry

R. Müller, R. Shegokar, C. Keck

2011.8.31Current Drug Discovery Technologies

DOI: 10.2174/157016311796799062

tlooto Summary

The lipid nanoparticles were developed as alternative to traditional carriers such as polymeric nanoparticles and liposomes and entered first the cosmetic market, and a pharmaceutical perspective for the future is given.

Abstract

Abstract is not available.

Citation format

MÜLLER, R.; SHEGOKAR, R.; KECK, C. 20 years of lipid nanoparticles (SLN & NLC): Present state of development & industrial applications. Current Drug Discovery Technologies, 2011, 8: 207–227.